Last reviewed · How we verify
OTF 2
At a glance
| Generic name | OTF 2 |
|---|---|
| Sponsor | Janssen Research & Development, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants (PHASE1)
- A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants (PHASE1)
- Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers (NA)
- Investigating a New Way of Giving Medicine to Newborn and Preterm Babies (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OTF 2 CI brief — competitive landscape report
- OTF 2 updates RSS · CI watch RSS
- Janssen Research & Development, LLC portfolio CI